| The prognostic value of MGMT promoter methylation in glioblastoma: a meta‐analysis of clinical trials MM Binabaj, A Bahrami, S ShahidSales, M Joodi, M Joudi Mashhad, ... Journal of cellular physiology 233 (1), 378-386, 2018 | 308 | 2018 |
| MicroRNAs as potential diagnostic and prognostic biomarkers in melanoma H Mirzaei, S Gholamin, S Shahidsales, A Sahebkar, MR Jaafari, ... European journal of cancer 53, 25-32, 2016 | 185 | 2016 |
| Targeting the Akt/PI3K signaling pathway as a potential therapeutic strategy for the treatment of pancreatic cancer S Ebrahimi, M Hosseini, S Shahidsales, M Maftouh, G A Ferns, ... Current medicinal chemistry 24 (13), 1321-1331, 2017 | 172 | 2017 |
| The prognostic and therapeutic application of microRNAs in breast cancer: Tissue and circulating microRNAs A Bahrami, A Aledavood, K Anvari, SM Hassanian, M Maftouh, ... Journal of cellular physiology 233 (2), 774-786, 2018 | 158 | 2018 |
| Therapeutic potential of targeting Wnt/β‐catenin pathway in treatment of colorectal cancer: rational and progress A Bahrami, F Amerizadeh, S ShahidSales, M Khazaei, ... Journal of cellular biochemistry 118 (8), 1979-1983, 2017 | 154 | 2017 |
| Therapeutic potential of targeting PI3K/AKT pathway in treatment of colorectal cancer: rational and progress A Bahrami, M Khazaei, M Hasanzadeh, S ShahidSales, M Joudi Mashhad, ... Journal of cellular biochemistry 119 (3), 2460-2469, 2018 | 138 | 2018 |
| The potential value of the PI3K/Akt/mTOR signaling pathway for assessing prognosis in cervical cancer and as a target for therapy A Bahrami, M Hasanzadeh, SM Hassanian, S ShahidSales, ... Journal of cellular biochemistry 118 (12), 4163-4169, 2017 | 129 | 2017 |
| GD2‐targeted immunotherapy and potential value of circulating microRNAs in neuroblastoma S Gholamin, H Mirzaei, SM Razavi, SM Hassanian, L Saadatpour, ... Journal of cellular physiology 233 (2), 866-879, 2018 | 111 | 2018 |
| Exosome-encapsulated microRNAs as potential circulating biomarkers in colon cancer M Hosseini, S Khatamianfar, S Mahdi Hassanian, R Nedaeinia, M Shafiee, ... Current pharmaceutical design 23 (11), 1705-1709, 2017 | 104 | 2017 |
| The therapeutic potential of PI3K/Akt/mTOR inhibitors in breast cancer: rational and progress A Bahrami, M Khazaei, S Shahidsales, SM Hassanian, M Hasanzadeh, ... Journal of cellular biochemistry 119 (1), 213-222, 2018 | 90 | 2018 |
| Targeting RAS signaling pathway as a potential therapeutic target in the treatment of colorectal cancer A Bahrami, SM Hassanian, S ShahidSales, Z Farjami, M Hasanzadeh, ... Journal of cellular physiology 233 (3), 2058-2066, 2018 | 86 | 2018 |
| Role of regulatory miRNAs of the PI3K/AKT/mTOR signaling in the pathogenesis of hepatocellular carcinoma F Rahmani, A Ziaeemehr, S Shahidsales, M Gharib, M Khazaei, GA Ferns, ... Journal of cellular physiology 235 (5), 4146-4152, 2020 | 81 | 2020 |
| Clinical significance and prognosis value of Wnt signaling pathway in cervical cancer A Bahrami, M Hasanzadeh, S ShahidSales, Z Yousefi, S Kadkhodayan, ... Journal of cellular biochemistry 118 (10), 3028-3033, 2017 | 74 | 2017 |
| The therapeutic potential of targeting tumor microenvironment in breast cancer: rational strategies and recent progress A Bahrami, SM Hassanian, M Khazaei, M Hasanzadeh, S Shahidsales, ... Journal of cellular biochemistry 119 (1), 111-122, 2018 | 69 | 2018 |
| Genetic susceptibility in cervical cancer: from bench to bedside A Bahrami, M Hasanzadeh, S Shahidsales, M Farazestanian, ... Journal of cellular physiology 233 (3), 1929-1939, 2018 | 63 | 2018 |
| The potential therapeutic and prognostic impacts of the c‐MET/HGF signaling pathway in colorectal cancer SM Parizadeh, R Jafarzadeh‐Esfehani, D Fazilat‐Panah, SM Hassanian, ... IUBMB life 71 (7), 802-811, 2019 | 53 | 2019 |
| Therapeutic potential of targeting the Wnt/β‐catenin pathway in the treatment of pancreatic cancer SA Javadinia, S Shahidsales, A Fanipakdel, M Joudi‐Mashhad, ... Journal of Cellular Biochemistry 120 (5), 6833-6840, 2019 | 53 | 2019 |
| Therapeutic potential of novel formulated forms of curcumin in the treatment of breast cancer by the targeting of cellular and physiological dysregulated pathways A Tajbakhsh, M Hasanzadeh, M Rezaee, M Khedri, M Khazaei, ... Journal of cellular physiology 233 (3), 2183-2192, 2018 | 52 | 2018 |
| C‐Met as a potential target for the treatment of gastrointestinal cancer: Current status and future perspectives A Bahrami, S Shahidsales, M Khazaei, M Ghayour‐Mobarhan, M Maftouh, ... Journal of cellular physiology 232 (10), 2657-2673, 2017 | 52 | 2017 |
| Evaluation of emotional distress in breast cancer patients H Saeedi-Saedi, S Shahidsales, M Koochak-Pour, E Sabahi, I Moridi Iranian journal of cancer prevention 8 (1), 36, 2015 | 49 | 2015 |
Saeideh SimabMashhad university of medical sciencesVerified email at mums.ac.ir
